Team (TISI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting will be held on June 18, 2025, with shareholders voting on four key proposals, including director elections, executive compensation, auditor ratification, and a charter amendment regarding director removal for cause.
Shareholders of record as of April 22, 2025, are entitled to vote, with multiple voting methods available, including online, phone, and mail.
The Board recommends voting in favor of all proposals and has provided detailed proxy materials and the 2024 Annual Report for review.
Voting matters and shareholder proposals
Proposal One: Election of J. Michael Anderson and Jeffrey G. Davis as Class III directors for a three-year term.
Proposal Two: Advisory (non-binding) vote on named executive officer compensation (say-on-pay).
Proposal Three: Ratification of KPMG LLP as independent auditor for fiscal year 2025.
Proposal Four: Approval of a charter amendment to align director removal for cause with Delaware law, requiring a majority vote at a shareholder meeting.
Shareholder proposals for the 2026 meeting must be submitted by December 30, 2025, for proxy inclusion.
Board of directors and corporate governance
The Board consists of seven directors divided into three classes, with recent additions and an average age of 62.
All directors except the Executive Chairman are independent under NYSE standards.
Board committees include Audit, Compensation, Corporate Governance and Nominating, and Executive Committees, all with independent chairs.
The Board regularly evaluates its leadership structure, currently featuring a separate Executive Chairman, CEO, and Lead Independent Director.
Annual self-evaluations and succession planning are conducted, with a focus on diversity in director recruitment.
Latest events from Team
- 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing24 Mar 2026 - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 20242 Feb 2026 - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 202415 Jan 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Flat Q1 revenue, $29.7M net loss, and refinancing set up at least 15% EBITDA growth for 2025.TISI
Q1 202525 Nov 2025 - Q2 revenue rose 8.5% to $248.0M, Adjusted EBITDA up 12.4%, with margin gains and transformation underway.TISI
Q2 202523 Nov 2025